Inventor · disambiguated record
William D. Shrader
Also filed as: SHRADER WILLIAM · SHRADER WILLIAM D · SHRADER WILLIAM DVORAK
22 granted patents·22 pending applications·267 citations·filing 1999–2023
95Inventor score
Files withEDISON PHARMACEUTICALS INC9BIOELECTRON TECH CORP7MILLER GUY M5REILEY PHARMACEUTICALS INC5AXYS PHARM INC3
Top patents by PatentIndex Score
44 records- 0198US7968746B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2008·Granted Jun 28, 2011·46 cites·14 claims
- 0296US8519001B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesJANKOWSKI ORION D·Filed 2011·Granted Aug 27, 2013·30 cites·20 claims
- 0395US9169196B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2013·Granted Oct 27, 2015·11 cites·24 claims
- 0495US8716527B22-substituted-p-quinone derivatives for treatment of oxidative stress diseasesHINMAN ANDREW W·Filed 2009·Granted May 6, 2014·35 cites·14 claims
- 0591US8299110B22-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitorsKOLESNIKOV ALEKSANDR·Filed 2011·Granted Oct 30, 2012·8 cites·2 claims
- 0688US7479502B22-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitorsPHARMACYCLICS INC·Filed 2003·Granted Jan 20, 2009·15 cites·8 claims
- 0786US9296712B2Resorufin derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·12 cites·19 claims
- 0886US6867200B1(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitorsAXYS PHARM INC·Filed 1999·Granted Mar 15, 2005·93 cites·13 claims
- 0984US8778625B22-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitorsKOLESNIKOV ALEKSANDR·Filed 2012·Granted Jul 15, 2014·3 cites·2 claims
- 1083US9090576B22-substituted-p-quinone derivatives for treatment of oxidative stress diseasesEDISON PHARMACEUTICALS INC·Filed 2014·Granted Jul 28, 2015·3 cites·22 claims
- 1182US9629815B2Benzoquinone derivatives for treating oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Granted Apr 25, 2017·5 cites·17 claims
- 1279US11840497B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesPTC THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·13 claims
- 1378US8729117B2Factor VIIa inhibitorPHARMACYCLICS INC·Filed 2012·Granted May 20, 2014·2 cites·7 claims
- 1476US8415328B2Factor VIIa inhibitorDICKMAN DANIEL A·Filed 2011·Granted Apr 9, 2013·4 cites·3 claims
- 1575US2024190790A1Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imagingREILEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1671US10968166B24-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesPTC THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·0 cites·9 claims
- 1768US9162986B22-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitorsPHARMACYCLICS LLC·Filed 2014·Granted Oct 20, 2015·0 cites·3 claims
- 1867US10167251B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesBIOELECTRON TECH CORP·Filed 2016·Granted Jan 1, 2019·0 cites·33 claims
- 1967US2022017432A1Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imagingREILEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2066US9546132B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2015·Granted Jan 17, 2017·0 cites·12 claims
- 2163US2009054432A12-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA InhibitorsPHARMACYLICS INC A DELAWARE CO·Filed 2008·Application pending·0 cites
- 2262US2019169084A1Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imagingREILEY PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2361US9181280B2Factor VIIa inhibitorPHARMACYCLICS LLC·Filed 2014·Granted Nov 10, 2015·0 cites·7 claims
- 2460US2018162784A1Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imagingREILEY PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2560US2022257533A1Methods and compositions for treatment of inflammation and oxidative stressPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2657US9850183B2Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imagingREILEY PHARMACEUTICALS INC·Filed 2015·Granted Dec 26, 2017·0 cites·12 claims
- 2755US2018116978A1Formulations of tocotrienol quinones for the treatment of ophthalmic diseasesBIOELECTRON TECH CORP·Filed 2017·Application pending·0 cites
- 2855US2014031433A1Formulations of tocotrienol quinones for the treatment of ophthalmic diseasesEDISON PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2954US2020121618A1Methods and compositions for treatment of inflammation and oxidative stressBIOELECTRON TECH CORP·Filed 2018·Application pending·0 cites
- 3051US2009291092A1Treatment of mitochondrial diseases with an erythropoietin mimeticMILLER GUY M·Filed 2009·Application pending·0 cites
- 3149US9868711B2Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disordersBIOELECTRON TECH CORP·Filed 2014·Granted Jan 16, 2018·0 cites·22 claims
- 3249US9670170B2Resorufin derivatives for treatment of oxidative stress disordersBIOELECTRON TECH CORP·Filed 2014·Granted Jun 6, 2017·0 cites·20 claims
- 3348US2010273892A1Formulations of tocotrienol quinones for the treatment of ophthalmic diseasesMILLER GUY M·Filed 2010·Application pending·0 cites
- 3448US2010056429A1Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activityMILLER GUY M·Filed 2008·Application pending·0 cites
- 3548US2005176797A12-[5-(5-Carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-YL]-succinic acid derivatives as factor viia inhibitorsAXYS PHARM INC·Filed 2004·Application pending·0 cites
- 3647US2008275250A1Factor Viia InhibitorPHARMACYCLICS INC·Filed 2005·Application pending·0 cites
- 3747US2017209393A1Benzoquinone derivatives for treating oxidative stress disordersBIOELECTRON TECH CORP·Filed 2017·Application pending·0 cites
- 3845US2003114457A12- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitorsAXYS PHARM INC·Filed 2002·Application pending·0 cites
- 3945US2016115141A1Carboxylic acid derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4041US2014275045A1Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4139US2019029975A1Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levelsBIOELECTRON TECH CORP·Filed 2017·Application pending·0 cites
- 4238US2013116336A1Treatment of ataxia telangiectasiaSHRADER WILLIAM D·Filed 2011·Application pending·0 cites
- 4336US2012136048A1Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseasesMILLER GUY M·Filed 2010·Application pending·0 cites
- 4434US2012295985A1Methods for improving blood glucose controlMILLER GUY M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William D. Shrader files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →